Regarding type III interferon secretion in tumors, TLR triggering could not further improve the high basal level of IFNλ1 secretion, and the polyI:C‐dependent secretion of IFNλ2 in tumor‐infiltrating cells was similar to controls (Figure 7). The gene discussed is IFNL2; the disease is neoplasm.